Sunday, November 3, 2024
HomeTagsThird Milestone

Third Milestone

Benevolentai Achieves Third Milestone in Its AI-Enabled Drug Discovery Collaboration With AstraZeneca

BenevolentAI, a leading clinical-stage AI-enabled drug discovery company, announces that AstraZeneca has selected an additional novel target for idiopathic pulmonary fibrosis (IPF) for its...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics